StocktoriaCNS Pharmaceuticals, Inc. CNSP
Nasdaq · XNAS · stock · Pharmaceutical Preparations
Chart by TradingView
1/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$16.0M | -$14.9M | -$18.9M | -$15.3M | -$14.5M |
| Net income | -$15.9M | -$14.9M | -$18.9M | -$15.3M | -$14.5M |
| Operating cash flow | -$13.8M | -$17.1M | -$14.1M | -$10.6M | -$13.5M |
| Free cash flow | -$13.8M | -$17.1M | -$14.1M | -$10.6M | -$13.5M |
| Total assets | $8.6M | $8.7M | $1.7M | $13.1M | $8.8M |
| Total liabilities | $4.1M | $2.5M | $6.1M | $4.9M | $2.6M |
| Shareholders' equity | $4.5M | $6.2M | -$4.4M | $8.1M | $6.2M |
| Ratios | |||||
| Return on assets | -183.8% | -170.8% | -1108.3% | -117.0% | -165.5% |
| Return on equity | -350.5% | -240.5% | 425.3% | -187.8% | -235.2% |
| Current ratio | 1.98 | 3.43 | 0.26 | 2.55 | 2.88 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001729427 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.